The MassGeneral Hospital for Children at the Lurie Center is currently recruiting for a research study that will evaluate the safety and effectiveness of an investigational medication, a cannabidiol oral solution (GWP42003-P; CBD-OS), for improving behavior, social communication, and overall symptom severity in children and adolescents with an autism spectrum disorder.
Participants must be:
- Between the ages of 6 and 17 (inclusive)
- Diagnosed with an autism spectrum disorder
For more information, please contact the
Lurie Center research team at:
Published on: Feb 15, 2022 at 17:06